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A novel γD-crystallin mutation causes mild changes in protein
properties but leads to congenital coralliform cataract
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Congenital cataract refers to lens opacification presented
at birth or developed shortly thereafter. Its prevalence is up to
7.2 per 10,000 live births and renders about 10% of childhood
blindness worldwide [1-7]. If left untreated, permanent visual
loss usually occurs. Various etiological factors have been
identified  including  infection,  metabolic  disorders,  and
genetic defects. About 18% of affected children have known
family history of cataract [8]. The most common mode of
genetic  lesion  is  a  single  gene  determinant  in  Mendelian
inheritance.  Autosomal  dominant  congenital  cataract
(ADCC) is a major form. Autosomal recessive and X-linked
inheritance  also  exists  [9].  According  to  the  outward
appearance,  size,  and  location  of  lens  opacity,  congenital
cataract (CC) is classified into various subtypes: whole lens,
nuclear,  lamellar,  cortical,  polar,  sutural,  pulverulent,
cerulean, coralliform, and other minor subtypes [10,11]. The
development  of  each  type  of  cataract  can  be  caused  by
distinctive  etiological  factors,  especially  defects  in  lens
crystallins [9].
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More than 20 genes out of 34 genetic loci mapped for
isolated congenital cataract have been identified with specific
mutations [12]. More than half of CC families carry mutations
in 10 crystallin genes (namely crystallin alpha A (CRYAA),
crystallin alpha B (CRYAB), crystallin beta B1 (CRYBB1),
crystallin beta B2 (CRYBB2), crystallin beta B3 (CRYBB3),
crystallin beta A1 (CRYBA1), crystallin beta A4 (CRYBA4),
crystallin  gamma  C  (CRYGC),  crystallin  gamma  D
(CRYGD) and crystallin gamma S (CRYGS). About 25% of
affected families have gene defects in membrane transport
genes (major intrinsic protein of lens fiber (MIP), gap junction
protein alpha 8 (GJA8), gap junction protein, alpha 3 (GJA3)
and transmembrane protein 114 (TMEM114)) [13] and lens
intrinsic  membrane  protein  2  (LIM2).  The  remaining  are
caused by mutations in genes encoding cytoskeletal proteins
(beaded filament structural protein 1 (BFSP1) [14] and beaded
filament structural protein 2 (BFSP2)), transcription factors
(paired-like  homeodomain  3  (PITX3),  v-maf
musculoaponeurotic  fibrosarcoma  oncogene  homolog
(MAF),  and  heat  shock  transcription  factor  4  (HSF4)),
chromatin  modifying  protein  (CHMP4B)  [15],  and
glucosaminyl transferase 2 (GCNT2) [16]. Forkhead box E3
(FOXE3), eyes absent homolog 1 (EYA1), and paired box gene
6 (PAX6) have been reported to cause congenital cataract in
some  patients  associated  with  other  anterior  segment
anomalies [9]. The same mutation in different families or even
within  a  family  can  result  in  drastically  different
morphologies and severity of lens opacification. On the other
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Purpose: To identify the genetic lesions for congenital coralliform cataract.
Methods: Two Chinese families with autosomal dominant coralliform cataract, 12 affected and 14 unaffected individuals,
were recruited. Fifteen known genes associated with autosomal dominant congenital cataract were screened by two-point
linkage analysis with gene based single nucleotide polymorphisms and microsatellite markers. Sequence variations were
identified. Recombinant FLAG-tagged wild type or mutant γD-crystallin was expressed in human lens epithelial cells and
COS-7 cells. Protein solubility and intracellular distribution were analyzed by western blotting and immunofluorescence,
respectively.
Results: A novel heterozygous change, c.43C>A (R15S) of γD-crystallin (CRYGD) co-segregated with coralliform
cataract in one family and a known substitution, c.70C>A (P24T), in the other family. Unaffected family members and
103 unrelated control subjects did not carry these mutations. Similar to the wild type protein, R15S γD-crystallin was
detergent  soluble  and  was  located  in  the  cytoplasm.  ProtScale  and  ScanProsite  analyses  revealed  raised  local
hydrophobicity and the creation of a hypothetical casein kinase II phosphorylation site.
Conclusions: A novel R15S mutation caused congenital coralliform cataract in a Chinese family. R15S possessed similar
properties to the wild type γD-crystallin, but its predicted increase of hydrophobicity and putative phosphorylation site
could lead to protein aggregation, subsequently causing opacification in lens.hand, similar or identical cataract presentation may arise from
mutations of different genes. These observations suggest that
additional genes or modifying factors such as environmental
regulators  could  play  important  roles  in  cataract  onset,
progression, and maturation.
CRYGD  is  a  structural  protein  essential  for  lens
transparency.  Mutations  of  CRYGD  are  common  genetic
lesions causing different types of congenital cataracts. Among
the  reported  families  with  congenital  cataract  caused  by
mutations of crystallin, one-third of them were associated with
CRYGD. Until now, a total of 11 cataract-causing mutations
(UniProt) have been reported including R15C, P24S, P24T,
R37S, R59H, G61C, E107A, Y134X, W156X, G165fsX8,
and R168W [17-21]. In this study, we added a novel R15S
mutation to this list, affirming a causative role of CRYGD in
coralliform type of congenital cataract.
METHODS
Affiliated  Hospital  (College  of  Medicine  at  Zhejiang
University; Family B; Figure 1). A total of 26 family members
including 12 affected and 14 unaffected individuals attended
this study, and informed consents were obtained from all
participants.  Unrelated  Chinese  control  subjects  (n=103)
attending the hospital clinics for ophthalmic examinations
were also recruited. They did not have any eye diseases except
senile  cataract  and  mild  floaters.  All  subjects  underwent
complete ophthalmoscopic examinations. Family history and
ophthalmic  examination  were  documented  by  senior
ophthalmologists. Peripheral venous blood was collected for
genomic DNA extraction using QIAamp DNA kit (Qiagen,
Valencia, CA).
Candidate  gene  screening:  Fifteen  candidate  genes  that
account  for  most  cases  of  ADCC  were  taken  for  linkage
analysis (Table 1). A gene exclusion strategy was conducted
by screening with single nucleotide polymorphisms (SNPs)
and  microsatellite  markers.  We  obtained  gene-based  SNP
markers in Han Chinese from HapMap with ABI SNP browser
v.3.5  (Applied  Biosystems,  Foster,  CA).  TaqMan  SNP
genotyping assay and allelic discrimination was conducted on
an ABI PRISM 7000 sequence detection system (Applied
Biosystems). For genes without informative SNP markers or
those that could not be excluded by SNP linkage analysis,
microsatellite  markers  flanking  to  the  target  genes  were
chosen  from  the  Marshfield  genetic  map.  GeneScan  was
conducted  on  ABIPRISM®  377  DNA  sequencer  (Applied
Biosystems).  The  pedigree  and  genotyping  data  were
managed by GenoPedigree 1.0 and GeneBase 2.0.1. (Applied
Biosystems). Two point LOD scores were calculated by the
MLINK  subprogram  of  FASTLINKAGE  v.4.1P.  A  gene
frequency of 0.0001 and penetrance of 100% were assumed
for ADCC.
Mutation  analysis:  All  coding  exons  and  splice  sites  of
CRYAA, CRYAB, CRYGC, CRYGD, and MAF were sequenced
using BigDye terminator v3.1 cycle sequencing kit (Applied
Biosystems) and specific primers (Table 2) and detected by
ABIPRISMTM 377 DNA sequencer. The data were compared
with sequences from NCBI GenBank (CRYAA: NM_000394,
CRYAB:  NG_009824;  CRYGC:  NM_020989;  CRYGD:
NM_006891.3; MAF: NM_001031804).
Computational analysis: Effects of amino acid changes on the
CRYGD  protein  structure,  the  isoelectric  point  (pI),  and
molecular  weight  (MW)  were  examined  by  Expasy
proteomics.  Local  hydrophobicity  was  predicted  by
ProtScale. The protein sequence was scanned by ScanProsite
to predict the effect of the mutation on specific motifs.
Figure  1.  Pedigree  of  coralliform
cataract families. The asterisk indicates
family  members  who  attended  this
study. The lens photograph from II-13
in Family A showed a line-shape opacity
with a larger white dot end and tubular
opacity radiating from the center of the
lens. The lens photograph from II-2 in
Family B showed a tubular and irregular
opacity  extending  from  center  of  the
lens. Large white dots accumulated at
the end of tubular protrusions.
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Patients and controls: This study adhered to the tenets of the
Declaration  of  Helsinki  and  was  approved  by  the  ethics
committees for medical research at The Chinese University of
Hong Kong (Hong Kong, China) and Zhejiang University
(Hangzhou, China). Two Chinese families with autosomal
dominant congenital cataract were recruited at the University
Eye Center (The Chinese University of Hong Kong; Family
A; Figure 1) and the Department of Ophthalmology at the FirstCRYGD expression, mutagenesis, and transfection: Human
full-length wild type CRYGD was cloned to p3XFLAG-myc-
CMV™-25  (Sigma,  St  Louis,  MO)  for  epitope  tagging  to
generate pFLAG/myc-CRYGDWT [19]. Missense mutations
were  introduced  by  a  site-directed  mutagenesis  kit
(Stratagene,  La  Jolla,  CA)  with  specific  oligonucleotides
(Table  3).  Correctness  of  the  construct  sequence  was
confirmed  by  direct  sequencing.  Preparation  of  pFLAG-
CRYGDG165fs was described as before [19]. Human lens B3
epithelial cells and COS-7 cells (ATCC, Manassas, VA) were
maintained  in  Eagle’s  minimum  essential  medium
(Invitrogen,  Carlsbad,  CA)  supplemented  with  10%  fetal
bovine serum and antibiotics [19]. Cells were seeded with
5×105  cells  in  a  60  mm  (diameter)  culture  dish  (Nunc,
TABLE 1. SNPS AND MICROSATELLITE MARKERS SELECTED IN 15 KNOWN ADCC CANDIDATE GENES FOR THE LINKAGE ANALYSIS.
Gene Gene ID Chromosome location SNPs STRs
CRYAA 1409 21q22.3 rs870137 D21S1890
        D21S266
        D21S1255
CRYAB 1410 11q22–22.3 rs2070894 D11S1986
      rs1940392 D11S4078
      rs14133 D11S1793
      rs10502149 D11S4151
CRYBB1 1414 22q11 rs4822752
      rs5752351
      rs2071859
      rs4822749
      rs5761618
CRYBB2 1415 22q11.2 rs739315 D22S315
      rs5752084 D22S1174
      rs969623
CRYBA1 1411 17q11.1–12 rs8080081
CRYGC 1420 2q33–35 rs2242071 D2S2208
      D2S2361
CRYGD 1421 2q33–35 rs2305429
GRYGS 1427 3q25-qter rs3774803 D3S1262
      rs11917060 D3S3570
      rs1447670
      rs4686428
MIP 4284 12q12 rs7953824 D12S1632
      rs2269348 D12S1691
      rs3809125
      rs10876890
GJA8 2703 1q21–25 rs7541950 D1S498
      rs2132397 D1S442
GJA3 2700 13q11–13 rs4769953
      rs1886176
BFSP2 8419 3q21–22 rs1153876 D3S1290
      rs666067 D3S3713
      rs4854585 D3S3657
      rs6762405 D3S1292
      rs931099
PITX3 5309 10q24–25 rs3758553 D10S1267
MAF 4094 16q23.2 rs2288066 D16S3040
        D16S504
        D16S503
HSF4 3299 16q22 Hcv25749941
      Hcv25613880
      rs11642409
      rs9033
Gene name, gene ID in NCBI GeneBank, and the chromosomal location for 15 candidate genes were shown in this table. All
single nucleotide polymorphism (SNP) markers and microsatellite markers used in this study were listed, respectively.
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1523Rochester,  NY)  overnight  before  transfection.  Expression
construct containing wild type or mutant CRYGD was mixed
with FuGene HD reagent (Roche, Basel, Switzerland) at a
ratio of 3 μl of FuGene per 1 μg of vector DNA in Opti-MEM®
I (Invitrogen) supplemented with GlutaMAX™-I (Invitrogen)
and incubated for 30 min. The mixture was then added to cells
for up to 48 h.
Detergent solubility of wild type and mutant CRYGD: Cells
transiently  expressing  wild  type  or  mutant  CRYGD  were
washed twice with ice-cold PBS and lysed in 2.5×106 cells/ml
lysis buffer, which contained 0.5% Triton X-100 (Tx; Sigma),
TABLE 2. SPECIFIC PRIMERS FOR DIRECT SEQUENCING.
Gene Amplicon Primer sequences
CRYAA 1 5′-CTCCAGGTCCCCGTGGTA
    5′-AGGAGAGGCCAGCACCAC
  2 5′-CTGTCTCTGCCAACCCCAG
    5′-CTGTCCCACCTCTCAGTGCC
  3 5′-AATGATCCTGCGATTTTGGAG
    5′-GGAAGCAAAGGAAGACAGACACC
CRYAB 1 5′-TGTAGCTGCAGCTGAAGGAG
    5′-TTCCAGTAAGGACTCTCCCG
  2 5′-GAAGGATGAATTACCCGGACAG
    5′-AGACATTGATTTGTAACCCCTGATC
  3 5′-GAGTTCTGGGCAGGTGATAAT
    5′-CTGGTGGGGAAACTTTCTTG
CRYGC 1 5′-TGCATAAAATCCCCTTACCGC
    5′-ACTCTGGCGGCATGATGG
  2 5′-AGACTCATTTGCTTTTTTCCATCC
    5′-GAATGACAGAAGTCAGCAATTGC
CRYGD 1 5′-CAGCAGCCCTCCTGCTAT
    5′-GCTTATGTGGGGAGCAAACT
  2 5′-CTTTTCTTCTCTTTTTATTTCTGGGTCC
    5′-GAAAGACACAAGCAAATCAGTGCC
MAF 1 5′-CTCCTGCAGCCCATCTGG
    5′-CTGGTGGCTGTTGCTGATG
  2 5′-CATCAGCAACAGCCACCAG
    5′-GAGAAGCGGTCGTCGAAGT
  3 5′-ACTTCGACGACCGCTTCTC
    5′-TGGCGAGCATGGCTCTAG
  4 5′-CCTTTACGCTGCGTTTGATC
    5′-AACCCCCAGACAAGAGGC
Five genes which were sequenced were listed. Forward and reverse primer sequences were provided for each amplicon of each gene.
TABLE 3. SENSE OLIGONUCLEOTIDES FOR SITE-DIRECTED MUTAGENESIS IN CRYGD.
Mutations Oligonucleotides with specific base change (underlined)
R15C 5′-GACCGGGGCTTCCAGGGCTGCCACTATGAATGCAGC
R15S 5′-GACCGGGGCTTCCAGGGCAGCCACTATGAATGCAGC
P24T 5′-GAATGCAGCAGCGACCACACCAACCTGCAGCCCTAC
G61C 5′-TACTTCCTGCGCCGCTGCGACTATGCCGAC
Constructs of four mutations in CRYGD   were made. The sense oligonucleotides used in site-directed mutagenesis experiment
were listed, respectively.
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1524for 2 min on ice [22]. After centrifugation, the Tx-soluble
fraction was collected and denatured in SDS buffer containing
50 mM DTT. The pellet containing Tx-insoluble proteins was
sonicated and denatured in SDS buffer containing 9 M urea.
Both  Tx-soluble  and  Tx-insoluble  proteins  equivalent  to
7.5×104  cells  were  analyzed  by  western  blotting  using
monoclonal  antibodies  against  FLAG,  Glyceraldehyde  3-
phosphate dehydrogenase (GAPDH), or β-actin (Sigma).
Immunofluorescence  staining:  Cells  grown  on  glass
coverslips were fixed with freshly prepared neutral buffered
2% paraformaldehyde (Sigma) and permeabilized with 0.05%
Tx  [22]  followed  by  incubations  with  mouse  monoclonal
antibodies against FLAG or mouse monoclonal antibodies
against  CRYGD  (Abnova,  Heidelberg,  Germany).
Rhodamine  Red-X  goat  anti-mouse  IgG  (Invitrogen)  was
applied as the secondary antibody. The nuclei were contrast-
stained with 4',6-diamidino-2-phenylindole (DAPI). The cells
were  examined  under  fluorescence  microscopy  (DMRB,
Leica, Germany), which was equipped with Spot RT color
system (Diagnostic Instruments Inc., Sterling Heights, MI).
RESULTS
Clinical investigations: Two pedigrees exhibited coralliform
type  of  cataract  in  an  autosomal  dominant  mode  of
inheritance.  All  affected  patients  had  bilateral  lens
opacification, characterized by the appearance of white lines
and processes extending from the nucleus to peripheral cortex,
resembling  the  shape  of  sea  coral  (Figure  1).  This  was
classified  as  the  coralliform  type  of  cataract  by  senior
ophthalmologists  in  two  eye  centers  (D.S.P.F.,  D.L.,  and
J.P.T.). The lens opacity was less severe in terms of size and
density in Family A than in Family B and did not result in
significant loss of visual acuity (VA). In family A, except for
one patient, II10, who had low vision due to high myopia, VA
Figure 2. R15S mutation in Family A.
A: The upper panel showed the forward
(on the left) and the reverse (on the right)
DNA  segments  of  wildtype  CRYGD.
The lower panel displayed the forward
and  the  reverse  sequences  of  mutant
CRYGD. The mutation of c.43C>A was
indicated by arrow both in forward and
reverse  sequences.  B:  The  DNA
sequences in the upper lines and amino
acid sequences in the lower lines were
compared between wildtype and mutant
CRYGD.  The  arrow  denotes  the
nucleotide change.
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Patient III-10 was recorded to have normal lens transparency
at his first eye examination at the age of 2.5 years, but he was
diagnosed  to  have  cataract  at  10  years  old.  Other  family
members were diagnosed after the age of five years. In Family
B, all patients showed cataract within the first year after birth.
The lens opacity caused obvious vision loss ranging from 0.04
to 0.7. Four of the six patients received cataract surgeries
before the age of 30.
Linkage  analysis  and  DNA  sequencing:  Through  linkage
analysis with selected SNPs and microsatellite markers (LOD
Figure 3. Hydrophobicity change of R15S CRYGD. The prediction
by  ProtScale  analysis  at  Expasy  indicated  an  increase  of  local
hydrophobicity around the site of R15S mutation (Circle in panel B).
A: The curve showed the hydrophobicity score of each amino acid
of wildtype CRYGD. B: The curve was the hydrophobicity of R15S
CRYGD. At the position of the 15th amino acid and its neighboring
locations, the hydrophobicity scores increased which was indicated
by the circle.
score equal to minus infinity), 10 ADCC-associated genes
were  excluded.  Five  other  genes  were  subject  to  direct
sequencing.  These  genes  were  CRYAA  (D21S1255;  LOD
score 0.3), CRYAB (D11S4151; LOD score 0.9), CRYGC,
CRYGD (D2S2361; LOD score 1.51), and MAF (D16S503;
LOD score 0.9) in Family A and CRYAB (D11S1793; LOD
score 2.41), CRYGC, and CRYGD (D2S2208; LOD score
2.41) in Family B. Two sequence variants in exon 2 of CRYGD
(NCBI accession number NM_006891.3) were identified to
segregate with cataract in these two families. In Family A, a
novel  missense  transversion,  c.43C>A,  which  led  to  a
substitution of arginine with serine at the 15th amino acid
position (R15S), was detected (Figure 2). In Family B, a
reported  missense  change,  c.70C>A,  which  substituted
proline with threonine at the 24th amino acid position (P24T),
was  found.  All  patients  showed  heterozygous  changes.
Neither the normal family members nor the 103 unrelated
healthy controls carried these changes.
Computational protein analysis of R15S CRYGD: By Expasy
proteomics, R15S CRYGD was predicted to have a reduced
isoelectric point (pI) of 6.58 (compared to 7.0 for the wild
type).  The  molecular  weight  (MW)  was  also  slightly
decreased (20.669 kDa for R15S CRYGD versus 20.738 kDa
for wild type). By ProtScale analysis, the local hydrophobicity
at and near the altered amino acid was increased (Figure 3). By
ScanProsite, a hypothetical casein kinase II phosphorylation
site was created due to the R15S mutation (Table 4).
Cell  specificity  of  R15S  CRYGD  solubility:  Recombinant
FLAG/myc-tagged  wild  type  or  cataract-causing  mutant
CRYGD (R15S, R15C, P24T, G61C, and G165fsX8) was
expressed in human lens epithelial B3 cells and COS-7 cells.
Tx-soluble and Tx-insoluble fractions were western blotted
for FLAG to detect wild type and mutant CRYGD proteins.
The result of expression in lens B3 cells showed that except
for G165fsX8, all known mutants of CRYGD remained Tx-
soluble, which is similar to the wild type protein (Figure 4).
The  majority  of  G165fsX8  was  present  as  Tx-insoluble.
However, when expressed in COS-7 cells, an appreciable
amount  of  mutant  CRYGD  protein  became  Tx-insoluble
(Figure 4) and wild type CRYGD remained Tx-soluble. Band
densitometry followed by normalization with housekeeping
proteins (GAPDH for Tx-soluble and β-actin for Tx-insoluble
fractions) revealed that about 8% of R15C and 17% of R15S
CRYGD were Tx-insoluble (compared to 0.2% of wild type
CRYGD). Similar observations were obtained in triplicate
experiments.
Cellular distribution: In COS-7 cells, recombinant FLAG/
myc-tagged R15S CRYGD was located predominantly in the
cytoplasm and slightly in the nuclei (data not shown). No
obvious  inclusion  was  observed.  This  was  similar  to  that
observed in cells expressing wild type CRYGD.
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In this study, we identified a novel R15S mutation and a P24T
change of CRYGD in two Chinese families showing ADCC
of the coralliform type, which is a rare subtype of bilateral
Figure 4. Detergent solubility assay of FLAG-tagged wild type and
mutant CRYGD. Western blotting analysis showed cell type specific
solubility changes of CRYGD mutants. When expressed in human
lens B3 epithelial cells (upper set of blots), wild type (WT) and all
known mutant CRYGD (including R15S), except G165fsX8, were
completely soluble in 0.5% Triton X-100 extraction. G165fsX8 was
mainly Tx-insoluble. When expressed in COS-7 cells (lower set of
blots), R15C and R15S CRYGD became moderately Tx-insoluble,
unlike  the  wild  type  and  P24T  and  G61C  mutants.  G165fsX8
remained Tx-insoluble.
static congenital cataracts characterized by the appearance of
opacity resembling the shape of sea coral. It shows white or
cerulean opacification arranged in fusiform or spindle shape,
extending from the center of the lens to the periphery but never
reaching the capsule [10,11]. The irregular pattern of opacity
running across the anatomic boundary of the cortical region
indicates  an  altered  arrangement  of  lens  fibers,  which
associates with light scattering and reduction of transparency
[11]. Until now, autosomal dominant transmission was the
only mode of inheritance reported for coralliform cataract.
Two loci, 2p24-pter and 2q33–35, have been mapped, and the
specific  gene,  CRYGD  (UniProt),  in  the  latter  locus  was
identified to associate with this cataract subtype [23]. Among
all CRYGD mutations, R15C, P24T, and G61C were reported
to be responsible for the coralliform phenotype [21,24-27]. In
this study, the novel R15S change in CRYGD was found to
cause  congenital  coralliform  cataract.  The  index  patient,
III-10, in in family A did not have a detectable lens opacity
when he was 2.5 years old but was diagnosed with cataract at
nine years of age. This was different from the effects of a
previously reported R15C mutation of CRYGD, which caused
the punctate type of congenital cataract at a much earlier age
of disease onset [28]. Human CRYGD exists as a monomeric
protein with a highly symmetric structure containing four
Greek key motifs organized into two highly homologous β-
sheet  domains.  The  NH2-terminal  and  COOH-terminal
domains are covalently connected by a six-residue linker and
interact non-covalently through the side chains of 10 amino
acids across the domain interface. Due to these two conserved
regions and a central hydrophobic domain interface, CRYGD
exhibits high intrinsic stability [29,30]. For the R15C mutant,
the additional reactive cysteine molecule at the protein surface
could lead to the formation of disulfide cross-linkage, which
in  turn  causes  protein  aggregation  [31].  Nevertheless,
substitution of the highly polar and charged arginine molecule
TABLE 4. COMPARISON OF WILD TYPE AND R15S CRYGD AMINO ACID SEQUENCES BY SCANPROSITE ANALYSIS.
Hypothetical sites Wild type R15S
Casein kinase II phosphorylation 5–8: TlyE 5–8: TlyE
    *15–18:ShyE
Protein kinase C phosphorylation 35–37: SaR 35–37: SaR
  75–77: SvR 75–77: SvR
  78–80: ScR 78–80: ScR
  87–89: ShR 87–89: ShR
  166–168: SlR 166–168: SlR
N-glycosylation 50–53: NYSG 50–53: NYSG
Cell attachment sequence 60–62: RGD 60–62: RGD
N-myristoylation 71–76:GLsdSV 71–76:GLsdSV
  158–163:GAtnAR 158–163:GAtnAR
Tyrosine kinase phosphorylation 91–98:Rly,EredY 91–98:Rly,EredY
All predicted functional sites in both wildtype and R15S CRYGD were listed in this table. The number is amino acid position.
The asterisk indicates the newly formed casein kinase II phosphorylation site in R15S CRYGD.
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effects  on  protein  conformation  than  the  formation  of  an
additional disulfide bond due to cysteine. Therefore, the R15S
mutant is associated with the less severe late onset of cataract
phenotype in our studied family. Although we detected no
alteration of biochemical properties due to R15S in our cell
expression  studies,  increased  hydrophobicity  at  the  R15S
mutation site as predicted by ProtScale might affect protein–
protein  interactions  since  R15  is  located  on  a  solvent
accessible  protein  surface  [28].  This  would  contribute  to
abnormal protein packing in the lens and would result in
aggregate formation and thus lens opacification. Moreover,
examination  by  ScanProsite  predicted  the  creation  of  a
putative casein kinase II phosphorylation site due to R15S.
Whether this posttranslational modification is associated with
protein  interactions  or  oligomerization  remains  to  be
investigated. Additionally, an animal study had shown that the
mutant γ-crystallin could cause cataract by the deposition of
the misfiled protein as amyloid-like inclusions [32]. But this
only explained those mutations which could affect protein
structure severely, such as a frameshift mutation leading to
protein  truncation,  ultimately  causing  mutant  protein
aggregate into inclusion. R15S was not supposed to have such
a severe influence on protein structure. No obvious inclusion
was observed in cells expressing R15S in this study.
The P24T mutant of CRYGD is associated with diverse
opacity  morphology  [24,25,33-35].  The  P24T  and  P24S
mutants [18] are responsible for different crystallin cataracts
such as the coralliform, aculeiform, fasciculiform, and crystal
forms. In vitro expression of P24T CRYGD demonstrated
reduced solubility when compared to the wild type protein
[36,37]. The additional formation of a hydrogen bond might
modify β-strand conformation, leading to protein insolubility
rather  than  loss  of  stability.  This  might  result  in  protein
aggregation and then opacification in the lens.
In  conclusion,  a  novel  R15S  mutation  and  a  P24T
mutation of CRYGD were identified in two Chinese families
showing the coralliform type of congenital cataract. Different
phenotypic  features  and  onset  time  of  disease  in  the  two
families accentuated the unique role of a single amino acid
change  in  protein  properties,  which  is  crucial  for  disease
pathogenesis.  The  enhanced  hydrophobicity  and  a
hypothetical phosphorylation site in the vicinity of R15S may
affect the CRYGD protein interaction and the formation of the
protein cluster.
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